Council Members in this Study Group: 190
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Gregory Buford, MDPlastic Surgeon and Medical Director
BEAUTY by BUFORD ![]()
Gregory Buford, MD, is a board-certified Plastic Surgeon and Medical Director at Beauty By Buford in Colorado, since January 2008. Dr. Buford has residencies in both General Surgery and Plastic Surgery at the Cleveland Clinic Foundation, in addition to a Cosmetic Surgery Fellowship at Plastic Surgery...
Plastic and Reconstructive Physician
Michael A Bain, MD ![]()
Michael Bain, MD, MS, is a Plastic and Reconstructive Physician in private practice based in Southern California. He has experience in all areas of plastic and reconstructive surgery including bariatric, breast, cosmetic, and reconstructive surgery. Dr. Bain’s interests are in the ever changing nature...
Robert Jacobs, MDPlastic Surgeon
COSMETIC SURGERY OF NEW YORK PC ![]()
Robert Jacobs, MD, is a Plastic Surgeon and Owner of Cosmetic Surgery of New York, an office based practice, since July 1978. He performs most major cosmetic procedures and has experience with all US approved breast implants in addition to being an investigator for Allergan implant trials. Dr. Jacob...
Michael Salzhauer, MDChief Surgeon
Bal Harbour Plastic Surgery Associates ![]()
Michael Salzhauer, MD, is the Chief Surgeon at Bal Harbour Plastic Surgery Associates, a plastic surgery private practice based in Florida. He has extensive expertise in all aspects of cosmetic surgery, including breast surgery augmentation, reduction, and lifting, face-lifting, liposuction, abdominoplasties...
Robert FrankOwner
Aria Cosmetic and Reconstructive Surgery ![]()
Robert Frank, MD, is a board certified Plastic Surgeon in private practice in Northwest Indiana. Dr. Frank has extensive expertise in general and plastic surgery procedures entering practice in 1997. He has special interest in breast and body contouring procedures, particularly cosmetic breast surgery....
Keith Denkler, MDAssociate Clinical Professor of Plastic Surgery
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO ![]()
Keith Denkler, MD, is a Plastic Surgeon in private practice in Marin County, California. Dr. Denkler is board certified in Plastic, Cosmetic and Reconstructive Surgery. He also serves as a Clinical Associate Professor of Plastic Surgery at UCSF and is an attending surgeon at Moffett/Long Hospitals....
Alan Zaccaria, MDPlastic Surgeon
MD ALAN FACS ZACCARIA ![]()
Alan Zaccaria, MD, FACS, is a double board certified Plastic Surgeon, in private practice in Little Silver, New Jersey. Dr. Zaccaria has expertise in breast reconstruction, breast implants, general reconstructive surgery, facial surgery, cosmetic surgery, skin cancer, botox and injectibles, comprehensive...
Scot Bradley Glasberg, MDAttending Staff Physician
LENOX HILL HOSPITAL ![]()
Scot Bradley Glasberg, MD, is a Cosmetic and Reconstructive Plastic Surgeon in private practice in New York. Dr. Glasberg is also on the Attending Staff at Lenox Hill and Manhattan Eye, Ear and Throat Hospitals. He holds numerous positions within national, regional, and local medical and specialtysocieties...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
GSK's cervical cancer vaccine Cervarix gains approval in Japan
October 19, 2009
GSK's cervical cancer vaccine Cervarix gains approval in Japan | www.pharmabiz.com
GlaxoSmithKline (GSK) gained approval for Cervarix in Japan, which becomes the first cervical cancer vaccine to be approved by the Japanese Ministry of Health, Labour and Welfare (MHLW). This approval marks a significant milestone for GSK, as Cervarix will be the first to be launched by the company's...
Researchers herald 'breakthrough' skin cancer therapy
September 27, 2009
Researchers herald 'breakthrough' skin cancer therapy | www.fiercebiotech.com
Plexxikon's early stage experimental melanoma drug PLX4032 looks like a "major breakthrough," says one leading researcher after reviewing new data from a small trial.
Sanofi Pasteur Commends Results of First HIV Vaccine
September 25, 2009
Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Some Effectiveness in Preventing HIV | www.pipelinereview.com
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), commended the results of the collaborative HIV vaccine trial that has been conducted in Thailand over the past six years. The Phase III clinical trial involving more than 16,000 adult volunteers in Thailand...
Roche's Herceptin provides impressive survival benefit
September 25, 2009
Roche's Herceptin provides impressive survival benefit in HER2-positive advanced gastric cancer | www.pharmabiz.com
A detailed analysis of the phase-III ToGA study revealed an unprecedented survival benefit for patients whose tumours exhibited a particularly high level of HER2 when Roche's Herceptin (trastuzumab) was added to standard chemotherapy (Xeloda or intravenous 5-FU and cisplatin). Based on the significant...
New Innovative Delivery System
September 15, 2009
Wyeth Launches New Innovative Delivery System For Enbrel(R) (etanercept) | www.medicalnewstoday.com
Enbrel (etanercept), Wyeth's biological treatment for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis, is now available as a new easy-to-use pre-filled auto-injector device, known as the Enbrel MYCLIC pen.